Latin-American Registry of Cardiovascular Disease and COVID-19: Final Results
Background: Socioeconomic factors contribute to a more severe impact of COVID-19 in Latin American and Caribbean (LA&C) countries than in developed countries. Patients with a severe or critical illness can develop respiratory and cardiovascular complications. Objective: To describe a LA&C po...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ubiquity Press
2023-11-01
|
| Series: | Global Heart |
| Subjects: | |
| Online Access: | https://account.globalheartjournal.com/index.php/up-j-gh/article/view/1272 |
| _version_ | 1797382799543500800 |
|---|---|
| author | Juan Esteban Gomez-Mesa Stephania Galindo Manuela Escalante-Forero Yorlany Rodas Andrea Valencia Eduardo Perna Alexander Romero Iván Mendoza Fernando Wyss José Luis Barisani Mario Speranza Walter Alarco Noel Alberto Flórez |
| author_facet | Juan Esteban Gomez-Mesa Stephania Galindo Manuela Escalante-Forero Yorlany Rodas Andrea Valencia Eduardo Perna Alexander Romero Iván Mendoza Fernando Wyss José Luis Barisani Mario Speranza Walter Alarco Noel Alberto Flórez |
| author_sort | Juan Esteban Gomez-Mesa |
| collection | DOAJ |
| description | Background: Socioeconomic factors contribute to a more severe impact of COVID-19 in Latin American and Caribbean (LA&C) countries than in developed countries. Patients with a severe or critical illness can develop respiratory and cardiovascular complications. Objective: To describe a LA&C population with COVID-19 to provide information related to this disease, in-hospital cardiovascular complications, and in-hospital mortality. Methods: The CARDIO COVID-19–20 Registry is an observational, multicenter, prospective, and hospital-based registry of patients with confirmed COVID-19 infection that required in-hospital treatment in LA&C. Enrollment of patients started on May 01, 2020, and ended on June 30, 2021. Results: The CARDIO COVID-19–20 Registry included 3260 patients from 44 institutions of 14 LA&C countries. 63.2% patients were male and median age was 61.0 years old. Most common comorbidities were overweight/obesity (49.7%), hypertension (49.0%), and diabetes mellitus (26.7%). Most frequent cardiovascular complications during hospitalization or reported at discharge were cardiac arrhythmia (9.1%), decompensated heart failure (8.5%), and pulmonary embolism (3.9%). The number of patients admitted to the Intensive Care Unit (ICU) was 1745 (53.5%), and median length of their stay at the ICU was 10.0 days. Support required in ICU included invasive mechanical ventilation (34.2%), vasopressors (27.6%), inotropics (10.3%), and vasodilators (3.7%). Rehospitalization after 30-day post discharge was 7.3%. In-hospital mortality and 30-day post discharge were 25.5% and 2.6%, respectively. Conclusions: According to our findings, more than half of the LA&C population with COVID-19 assessed required management in ICU, with higher requirement of invasive mechanical ventilation and vasoactive support, resulting in a high in-hospital mortality and a considerable high 30-day post discharge rehospitalization and mortality. |
| first_indexed | 2024-03-08T21:10:39Z |
| format | Article |
| id | doaj.art-ae5ba2cb1a6940b09565ba88608dff12 |
| institution | Directory Open Access Journal |
| issn | 2211-8179 |
| language | English |
| last_indexed | 2024-03-08T21:10:39Z |
| publishDate | 2023-11-01 |
| publisher | Ubiquity Press |
| record_format | Article |
| series | Global Heart |
| spelling | doaj.art-ae5ba2cb1a6940b09565ba88608dff122023-12-22T06:33:32ZengUbiquity PressGlobal Heart2211-81792023-11-01181606010.5334/gh.12721253Latin-American Registry of Cardiovascular Disease and COVID-19: Final ResultsJuan Esteban Gomez-Mesa0https://orcid.org/0000-0002-6635-6224Stephania Galindo1https://orcid.org/0000-0002-6347-0996Manuela Escalante-Forero2https://orcid.org/0000-0002-2822-0887Yorlany Rodas3https://orcid.org/0000-0002-7344-6156Andrea Valencia4https://orcid.org/0000-0001-6855-207XEduardo Perna5https://orcid.org/0000-0002-9977-7623Alexander Romero6https://orcid.org/0000-0002-0785-0804Iván Mendoza7https://orcid.org/0000-0002-9098-8424Fernando Wyss8https://orcid.org/0000-0003-1700-4692José Luis Barisani9https://orcid.org/0000-0002-2206-8466Mario Speranza10https://orcid.org/0000-0002-6947-0735Walter Alarco11https://orcid.org/0000-0001-5881-4080Noel Alberto Flórez12https://orcid.org/0000-0001-8714-7168Fundación Valle del Lili, CaliFundación Valle del Lili, CaliFundación Valle del Lili, CaliFundación Valle del Lili, CaliFundación Valle del Lili, CaliInstituto de Cardiología J.F Cabral, CorrientesHospital Santo Tomas, Ciudad de PanamaUniversidad Central de Venezuela, CaracasServicios y Tecnología Cardiovascular de Guatemala S.A – Cardiosolutions, Ciudad de GuatemalaClínica Adventista Belgrano, Buenos AiresHospital Clínica Bíblica, San JoseInstituto Nacional Cardiovascular INCOR ESSALUD, LimaFundación Valle del Lili, CaliBackground: Socioeconomic factors contribute to a more severe impact of COVID-19 in Latin American and Caribbean (LA&C) countries than in developed countries. Patients with a severe or critical illness can develop respiratory and cardiovascular complications. Objective: To describe a LA&C population with COVID-19 to provide information related to this disease, in-hospital cardiovascular complications, and in-hospital mortality. Methods: The CARDIO COVID-19–20 Registry is an observational, multicenter, prospective, and hospital-based registry of patients with confirmed COVID-19 infection that required in-hospital treatment in LA&C. Enrollment of patients started on May 01, 2020, and ended on June 30, 2021. Results: The CARDIO COVID-19–20 Registry included 3260 patients from 44 institutions of 14 LA&C countries. 63.2% patients were male and median age was 61.0 years old. Most common comorbidities were overweight/obesity (49.7%), hypertension (49.0%), and diabetes mellitus (26.7%). Most frequent cardiovascular complications during hospitalization or reported at discharge were cardiac arrhythmia (9.1%), decompensated heart failure (8.5%), and pulmonary embolism (3.9%). The number of patients admitted to the Intensive Care Unit (ICU) was 1745 (53.5%), and median length of their stay at the ICU was 10.0 days. Support required in ICU included invasive mechanical ventilation (34.2%), vasopressors (27.6%), inotropics (10.3%), and vasodilators (3.7%). Rehospitalization after 30-day post discharge was 7.3%. In-hospital mortality and 30-day post discharge were 25.5% and 2.6%, respectively. Conclusions: According to our findings, more than half of the LA&C population with COVID-19 assessed required management in ICU, with higher requirement of invasive mechanical ventilation and vasoactive support, resulting in a high in-hospital mortality and a considerable high 30-day post discharge rehospitalization and mortality.https://account.globalheartjournal.com/index.php/up-j-gh/article/view/1272coronaviruscovid-19latin americacaribbeansars-cov-2heart failure |
| spellingShingle | Juan Esteban Gomez-Mesa Stephania Galindo Manuela Escalante-Forero Yorlany Rodas Andrea Valencia Eduardo Perna Alexander Romero Iván Mendoza Fernando Wyss José Luis Barisani Mario Speranza Walter Alarco Noel Alberto Flórez Latin-American Registry of Cardiovascular Disease and COVID-19: Final Results Global Heart coronavirus covid-19 latin america caribbean sars-cov-2 heart failure |
| title | Latin-American Registry of Cardiovascular Disease and COVID-19: Final Results |
| title_full | Latin-American Registry of Cardiovascular Disease and COVID-19: Final Results |
| title_fullStr | Latin-American Registry of Cardiovascular Disease and COVID-19: Final Results |
| title_full_unstemmed | Latin-American Registry of Cardiovascular Disease and COVID-19: Final Results |
| title_short | Latin-American Registry of Cardiovascular Disease and COVID-19: Final Results |
| title_sort | latin american registry of cardiovascular disease and covid 19 final results |
| topic | coronavirus covid-19 latin america caribbean sars-cov-2 heart failure |
| url | https://account.globalheartjournal.com/index.php/up-j-gh/article/view/1272 |
| work_keys_str_mv | AT juanestebangomezmesa latinamericanregistryofcardiovasculardiseaseandcovid19finalresults AT stephaniagalindo latinamericanregistryofcardiovasculardiseaseandcovid19finalresults AT manuelaescalanteforero latinamericanregistryofcardiovasculardiseaseandcovid19finalresults AT yorlanyrodas latinamericanregistryofcardiovasculardiseaseandcovid19finalresults AT andreavalencia latinamericanregistryofcardiovasculardiseaseandcovid19finalresults AT eduardoperna latinamericanregistryofcardiovasculardiseaseandcovid19finalresults AT alexanderromero latinamericanregistryofcardiovasculardiseaseandcovid19finalresults AT ivanmendoza latinamericanregistryofcardiovasculardiseaseandcovid19finalresults AT fernandowyss latinamericanregistryofcardiovasculardiseaseandcovid19finalresults AT joseluisbarisani latinamericanregistryofcardiovasculardiseaseandcovid19finalresults AT mariosperanza latinamericanregistryofcardiovasculardiseaseandcovid19finalresults AT walteralarco latinamericanregistryofcardiovasculardiseaseandcovid19finalresults AT noelalbertoflorez latinamericanregistryofcardiovasculardiseaseandcovid19finalresults |